U.S. Banks Stock News

Reddit (NYSE:RDDT) has approved a $1b share repurchase program, aiming to buy back its own stock over time. The company has also been fined £14.47m by the UK's Information Commissioner's Office for child data privacy violations. These developments come as Reddit's share price stands at $136.0 after a 9.6% gain over the past week and a 43.8% decline year to date. Reddit's recent moves present a mixed picture to consider. On one side, the $1b buyback signals that management is prepared to...

In early April 2026, Baron Capital reiterated its positive stance on Host Hotels & Resorts in its Q4 2025 fund letter, while the company also received Nareit’s 2026 Leader in the Light Award for Operations for large-cap REITs, recognizing its sustainability and operational practices. Together, the institutional endorsement and sustainability recognition underscore how Host links environmental and social initiatives with financial discipline, strengthening its appeal to long-term, ESG-focused...

We can readily understand why investors are attracted to unprofitable companies. Indeed, vTv Therapeutics ( NASDAQ:VTVT...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Procore Technologies (PCOR) has reshuffled its top leadership, naming Rachel Pyles as Chief Financial Officer and Walt Hearn as Chief Revenue Officer, while reaffirming its 2026 guidance and continued focus on AI driven platform expansion. See our latest analysis for Procore Technologies. The leadership reshuffle comes as the share price trades at US$58.02, with a 7 day share price return of 4.05% and a 90 day share price return showing a 22.14% decline, while the 3 year total shareholder...

Keybanc analyst Aleksey Yefremov recently shifted his rating on Avient (AVNT) from Overweight to Sector Weight, a change that puts fresh attention on how the stock compares with its peers. See our latest analysis for Avient. Avient shares recently pulled back, with a 1 day share price return of a 3.65% decline and a 30 day share price return of a 4.15% decline. However, the 1 year total shareholder return of 21.30% and the year to date share price return of 10.60% suggest momentum has...

In March 2026, Brightstar Lottery PLC entered into new senior secured multicurrency revolving credit facilities totaling US$650 million and €1,000 million, aligning covenants across its major debt agreements and refinancing older facilities to support general corporate purposes. By locking in a five-year funding backstop with terms linked to its public credit ratings, Brightstar Lottery has materially expanded its financial flexibility and tightened the link between its borrowing costs and...

Valley National Bancorp (VLY) is back in focus after JPMorgan reiterated its Overweight rating while trimming its price target, as investors weigh the bank’s 25 million share buyback and broader capital plans. See our latest analysis for Valley National Bancorp. That reassessment has cooled very short term enthusiasm, with a 1 day share price return of a 0.16% decline, but the 7 day share price return of 4.37% and 1 year total shareholder return of 59.59% suggest momentum has been building...

Relay Therapeutics recently announced that initial clinical and preclinical data for its PI3Kα inhibitor zovegalisib in vascular anomalies will be presented at the International Society for the Study of Vascular Anomalies World Congress 2026 in May, based on results that supported advancing the regimen into the ongoing Phase 3 ReDiscover-2 trial. By aiming a mutant-selective PI3Kα inhibitor at both PIK3CA-driven vascular anomalies and certain breast cancers, Relay Therapeutics is linking a...

CSG Systems International (NasdaqGS:CSGS) has entered a significant partnership with ePLDT Group to support digital solutions and enterprise services in the Philippines. The collaboration extends CSG’s platform solutions into a new Southeast Asian market within the region’s information and communications technology sector. The agreement focuses on helping enterprise clients streamline and manage their digital offerings across a growing set of services. CSG Systems International, known for...

In Q4 2025, Halozyme Therapeutics reported EPS of US$0.24 and revenue of US$451.77 million, exceeding revenue expectations but falling short on earnings, while reiterating its 2026 revenue guidance, updating 2025 guidance, and appointing David Ramsay as interim CFO on March 23, 2026. Despite the mixed quarter, analysts highlighted Halozyme’s growing royalty revenues and expanding ENHANZE partnerships as key drivers behind their more optimistic outlooks. With stronger revenue performance and...

In recent months, Tenet Healthcare reported quarterly revenue of US$5.53 billion and earnings per share of US$4.70, both ahead of consensus estimates, while analysts have become more positive on its earnings outlook. An orderly transition in Tenet’s senior finance leadership, paired with consistent earnings outperformance, highlights how its financial reporting function underpins investor confidence. We’ll now examine how Tenet’s continued earnings outperformance shapes its investment...

In March 2026, Arrowhead Pharmaceuticals reported two-year open-label extension data showing durable triglyceride reductions and consistent safety for investigational plozasiran in patients with severe and mixed hypertriglyceridemia, building on earlier Phase 2b results and supporting ongoing global Phase 3 programs and regulatory plans. The data underscored plozasiran’s potential to address a lack of long-term treatment options in severe lipid disorders, including rare Familial...

QCR Holdings, Inc. recently reported it would release its first-quarter 2026 results after market close on April 22, 2026, followed by a conference call and webcast on April 23 for investors and analysts. Ahead of that update, the board lifted the quarterly cash dividend to US$0.10 per share from US$0.06 and raised the upper end of capital markets revenue guidance to US$70.00 million, underscoring management’s emphasis on returning capital while leaning into its capital markets...

Why Core Natural Resources is on investors’ radar Core Natural Resources (CNR) recently caught investor attention as trading data highlighted a mix of short term volatility and longer term strength, with the stock moving in different directions over the past week, month and past 3 months. See our latest analysis for Core Natural Resources. At a share price of $104.25, Core Natural Resources sits on a 30 day share price return of 19.97% and a 1 year total shareholder return of 61.46%. This...

In March 2026, Viatris announced that Japan's Ministry of Health, Labour and Welfare approved Effexor SR capsules for treating adults with generalized anxiety disorder, making it the first and only approved GAD therapy in Japan based on positive Phase 3 data in Japanese patients. This approval highlights Viatris's ability to expand indications for existing medicines into areas of unmet need, while its pipeline progress in Japan contrasts with setbacks such as the recent Phase 3 failure of...

How Watts Water Technologies Stock Has Been Trading Watts Water Technologies (WTS) has seen mixed share performance recently, with a 1 day return of a 1.4% decline, a slight gain over the past week, and a negative return over the past month. Over the past 3 months the stock shows a positive total return, while year to date and 1 year figures are also positive. Over the longer term, 3 year and 5 year total returns are in very large multiples compared with the starting point. See our latest...

In its recent Q4 2025 earnings call, H World Group Limited reported strong profit growth, solid cash generation, and an accelerated asset-light expansion plan that includes opening 2,200–2,300 hotels and closing 600–700 properties in 2026 to refine its portfolio. A key insight from this update is the increasing weight of fee-based franchise and manachised operations in H World’s earnings mix, underlining a pivot toward less capital-intensive growth. We will now examine how H World’s...

In recent weeks, Entergy has secured Meta’s fully funded US$10.00 billion data center project, tying its Gulf Coast power network more closely to fast-growing AI-related electricity demand. This agreement not only concentrates a large, long-duration customer within Entergy’s service territory, but also highlights how hyperscale data centers can reshape utility capital planning, risk exposure, and long-term earnings profiles. With Meta’s massive data center commitment in place, we’ll now...

Why AtriCure (ATRC) Is Back on Investors’ Radar AtriCure (ATRC) drew fresh attention after reporting Q4 2025 earnings with 15% revenue growth, followed by share price pressure linked to a JPMorgan downgrade and a reduced price target from UBS. See our latest analysis for AtriCure. Despite the recent Q4 earnings momentum, AtriCure’s share price has been under pressure, with a 90 day share price return showing a 28.26% decline and a 1 year total shareholder return showing a 7.15% decline,...

Hanover Insurance Group (THG) continues to attract attention after recent share price moves, with the stock closing at US$176.10. Investors are weighing this level against the company’s returns, value score and profitability profile. See our latest analysis for Hanover Insurance Group. The recent 2.2% 1 day share price return and 4% 7 day share price return sit against a slightly weaker 90 day share price return of 2.4% decline. However, the 1 year total shareholder return of 14.1% and 3 year...

In recent days, JPMorgan downgraded TIC Solutions, Inc. to Underweight from Neutral, citing concerns around near-term growth, operational execution, margin pressures, and the integration of NV5, while the company also authorized a US$200,000,000 share repurchase program to return capital to investors. This combination of a more cautious analyst stance alongside a sizable buyback plan highlights the tension between execution risks and management’s confidence in the business. We’ll now explore...

In the past quarter, Icahn Enterprises LP reported Q4 2025 results that missed analyst expectations on both earnings per share and revenue across its diversified portfolio of energy, automotive, food packaging, and real estate operations. While analysts are projecting very large earnings per share growth next year even as revenue is expected to decline, the latest earnings shortfall raises questions about how quickly the business can translate its multi-segment footprint into more consistent...

REX American Resources (REX) has drawn fresh attention after reporting fourth quarter and full year results showing much higher net income and earnings per share, alongside a recent share sale by its chief financial officer. See our latest analysis for REX American Resources. The shares have been volatile around the results and insider sale, with a 2.14% one-day share price gain but a 4.86% seven-day share price decline. This is set against a 21.48% 30-day share price return, a 42.26% 90-day...